Zydus’ biopharma arm acquires global proprietary rights for Progeria treatment
IndiaTimes
Sentynl, under Zydus Lifesciences, acquired global rights for Zokinvy, the first FDA-approved Progeria treatment. An acquisition..
Sentynl, under Zydus Lifesciences, acquired global rights for Zokinvy, the first FDA-approved Progeria treatment. An acquisition..
Zydus Lifesciences was cofounded by his late father in 1952 with his business partner Indravadan Modi to make vitamins.
Investors can contact the law firm at no cost to learn more about recovering their lossesLOS ANGELES, March 04, 2024 (GLOBE..